We have analyzed the expression pattern and localization of MLE, MSL-1, MSL-2, and histone H4Ac16 during embryogenesis to determine when m&dependent dosage compensation begins. Maternal MSL-1 and MLE are present in both sexes at fertilization.
Introduction
In organisms with a chromosomal basis for sexual dimorphism, it is thought that a pair of chromosomes evolved to have one sex maintaining the original karyotype (XX) and the other acquiring a specialized Y chromosome (XY) or losing one sex chromosome (X0). Because the X chromosome encodes non-sex-specific products, heterogametic organisms also evolved a mechanism to avoid the genetic imbalance caused by the difference in X-linked gene dosage in the two sexes. This balancing mechanism was first defined and named dosage compensation by Muller (1950) . Like sex determination, a variety of solutions for dosage compensation are used in different species. In mammals one of the two X chromosomes present in females is inactivated to form the Barr body (reviewed in Borsani and Ballabio, 1993) . In C. elegans the expression of each X chromosome in the hermaphrodite is reduced to half that of the single male X chromosome (reviewed in Hsu and Meyer, 1993) . In Drosophila, the transcription of most genes on the single X chromosome in males is increased to equal that of both Xs in females (reviewed in Baker et al., 1994 The biochemical mechanism of X chromosome hypertranscription in Drosophila is not known. Several sexspecific lethal mutants that affect dosage compensation have been characterized, and four of these are malespecific lethals: male-specific lethal-l (m&l), malespecific lethal-2 (msl-2) (Belote and Lucchesi, 1980) , maleless on the third (mle 3, renamed msl-3) (Uchida et al., 1981; Lucchesi et al., 1982) and maleless (mle) (Fukunaga et al., 1975) . These genes and their products are collectively designated the msl genes or MSL proteins. Loss of function mutations in each of these loci are lethal to males during the late larval/early pupal stages but they have no effect on the viability or fertility of females. There are slight differences in the phenotypes associated with msl mutations; maternal effects on the lethal phase are associated with msl-I, msl-3 and mle but not with msl-2 (Tanaka et al., 1976; Belote and Lucchesi, 1980; Uchida et al., 1981) and only mle was shown to be required in the male germline (Bachiller and Sanchez, 1986) while msl-1 and msl-2 are not required and msl-3 was not tested.
MLE shows similarity to the DExH subfamily of putative RNA helicases (Kuroda et al., 1991; Fuller-Pace, 1994) . MSL-1 is not closely related to proteins in the database but contains clusters of Asp/Glu residues characteristic of proteins involved in chromatin modeling and tran-scription (Palmer et al., 1993) . MSL-2 (Kelley et al., 1995; Zhou et al., 1995) contains a cysteine-rich sequence known as the 'RING' finger motif (Lovering et al., 1993) , that is a Zn2+ binding domain found in a number of proteins thought to interact with nucleic acids. Drosophila members of this family, Psc and Sufz)Z, form part of a putative regulatory complex which associates specificahy with repressed chromatin (for review see Paro, 1993; Pirrotta and Rastelli, 1994) . The msl-3 gene encodes a novel protein (Gorman et al., 1995) .
The MLE, MSL-1, MSL-2 and MSL-3 proteins colocalize at hundreds of sites along the euchromatic part of the male, but not the female, X chromosomes (Bone et al., 1994; Gorman et al., 1995; Kelley et al., 1995; Zhou et al., 1995) . The association of the MSLs with the male X correlates with the presence of an isoform of histone H4, specifically acetylated at Lysine 16 (H4Acl6) (Turner et al., 1992; Bone et al., 1994) . Histone H4Acl6 may be an important feature of the more active X chromosome, which displays a diffuse cytological appearance when compared to the other polytene chromosomes in males. The wild type activity of each msl is required for the association of the other MSLs and of H4Ac16 in hundreds of bands along the male X chromosome (Gorman et al., 1993; Bone et al., 1994; Hilfiker et al., 1994; Gorman et al., 1995; L. Lyman and M.I.K., unpublished) .
In addition, co-immunoprecipitation experiments reveal that MSL-I and MSL-2 are physically associated in male nuclear extracts (Kelley et al., 1995) . Collectively, these observations support the existence of an MSL protein complex. The formation of this complex may be required prior to association with the X chromosome. Alternatively, complex formation may be needed for maintenance of these proteins on the X subsequent to binding. In this case at least one of the MSLs might recruit the other members to the X. The two alternative hypotheses could potentially be distinguished during the very early phases of msl expression, by asking whether the MSL proteins are interdependent for their initial association with the X chromosome.
The sex-specificity of dosage compensation is set early in embryonic development by the ratio of X chromosomes to sets of autosomes (X:A ratio), which directs female-specific expression of Sex lethal (SxE) (Cline, 1993) . SxZ encodes an RNA binding protein that regulates sexual differentiation by influencing alternative splicing in the sex determination hierarchy (Bell et al., 1988; Sosnowski et al., 1989; Inoue et al., 1990; Samuels et al., 1994) . Sxl also prevents X chromosome hypertranscription in females (Lucchesi and Skripsky 1981; Cline 1983; Cline 1984) . The molecular target of Sxl repression is thought to be the rnsZ-2 mRNA, as there are clustered optimal SXL binding sites in the 5' and 3' untranslated regions (UTRs) of the msl-2 transcript, and translation of MSL-2 is male-specific (Kelley et al., 1995; Zhou et al., 1995) . Ectopic expression of MSL-2 in females circumvents Sxl regulation of X hypertranscription, resulting in a female-specific developmental delay, decreased viability and sterility (Kelley et al,, 1995) .
Three observations have lead to the idea that the msl pathway controls dosage compensation during the larval and pupal stages, but that a different mechanism is at work during embryogenesis.
First, msl mutant males complete embryogenesis with normal pattern formation, but die as Iate larvae or pupae (Fukunaga et al., 1975; Belote and Lucchesi, 1980; Uchida et al., 1981; Lucchesi et al., 1982) . Second, the female embryonic lethality caused by Sxl mutations cannot be rescued by loss of msl function Uenoyama et al., 1982; Cline, 1983; Cline 1984; Uenoyama, 1984 ; T.W. Cline unpublished result in Bernstein and Cline, 1994) . Third, the only X-linked gene to be tested in embryogenesis, runt, is regulated by a Sxl-dependent, m&independent mechanism (Gergen, 1987 ).
An alternative model for the relationship between the two dosage compensation pathways is that they act in parallel during development, either in separate tissues (Cline, 1984) or on separate sets of genes (Kelley et al., 1995) . In support of this view, recent genetic data suggest that the m&independent mechanism may function throughout development (Bernstein and Cline, 1994) . We have examined the relationship between the two dosage compensation pathways by asking when m&dependent hypertranscription of the male X begins. We analyzed the expression pattern of MSL-1, MSL-2, MLE, and histone H4Ac16 in early embryogenesis and found that (1) the MSL proteins and histone H4Ac16 are localized to one chromosome during embryogenesis, and (2) the MSLs are interdependent initially as they are later in development. Our findings support a model in which two dosage compensation mechanisms act in parallel during early Drosophila development.
Results
2.1. Sex-specificity and sub-nuclear localization of the
MSL proteins
Previous expression studies of the MSL dosage compensation regulators focused on examination of third instar larvae. We immunostained whole mount embryos with affinity-purified antibodies raised against the MSLS to determine if these proteins are detectable during embryogenesis, and if so, whether the proteins are sexspecific in expression or sub-nuclear localization. By stage 9, we detected MSL-1, MSL-2, and MLE in male embryos in punctate, subnuclear dots, which we presume represents localization to the X chromosome ( Fig. 1 ). MSL-I was not detectable in female embryos at this stage, but seen transiently in both sexes at earlier stages (data not shown), consistent with deposition of maternal protein into the egg (see below). MLE was detected in females throughout embryogenesis, but had no sub- In wild type males all three antigens (MSL-I, MSL-2 and MLE) are readily detected by stage 9 and at high magnification the MSL signal appears as localized dots/patches inside the nuclei. In wild type females MSL-2 is not detected, MSL-1 is detected as a very weak diffuse staining and MLE is present in appreciable amounts but is not localized. The controls are males embryos which lack the msl maternally and zygotically and thus do not react with the antisera.
nuclear localization. MSL-2 was never detected in female embryos. The sex-specificity of the MSL proteins in embryos is analogous to the pattern observed in third instar larvae, and consistent with evidence that MSL-2, which lacks a maternal component, is the key malelimited regulator of dosage compensation (Kelley et al., 1995) .
The specificities of the anti-MSL-1, anti-MSL-2 and anti-MLE antibodies were confirmed by staining the progeny of msUms1 mothers crossed to msKyOwglacZ males. Half of this population consists of homozygous mutants, recognized by lack of anti B-galactosidase staining (see Section 4). Half of these mutants should be males, but none of these embryos had detectable signal ( Fig. I) , while in the heterozygous brothers we observed staining. The specificity of the anti-MSL-2 antibodies was confirmed by a second experiment.
msl-2/msl-2 males which carry a P(msl-2+) transposon inserted on the X chromosome (Kelley et al., 1995 and R. Kelley, pers. commun.) were crossed to msl-2/msl-2 females. Only the female progeny receive the transposon and wild type females do not express this MSL-2 protein. We did not detect MSL-2 staining in any embryo from this cross (data not shown).
In order to ask when the MSL proteins are first detected, we examined the temporal expression of MSL-1, MSL-2 and MLE during embryogenesis.
Total protein extracts made from synchronized embryos at different stages were probed on Western blots with anti-MSL-1 ( Fig. 2A) , anti-MSL-2 ( Fig. 2B ) and anti-MLE (Fig. 2C) . We found that MSL-1 and MLE were present at all stages, even in unfertilized eggs, consistent with the msl-I and mle maternal effects (Tanaka et al., 1976; Belote and Lucchesi, 1980) . In embryos produced by mothers homozygous for msl-I~269 crossed to wild type males ( Fig. 2A , no mat.) the amount of MSL-1 in embryos aged between 1 and 5 h was extremely reduced when compared with embryos of similar age derived from wild type mothers. Significant levels of MSL-1 protein were detected in progeny of homozygous msl-Iv269 mothers that were aged more than 7 h, indicating that zygotic expression had been established. The amount of MLE in embryos from homozygous mle' mothers aged between 1 and 5 h was detectable, but also extremely reduced until after 7 h (Fig.  2C , no mat.). Examination of whole mount embryos produced by homozygous msl-I-and mle-mothers confirmed that these male embryos, lacking the maternal MSL-1 or MLE components, did not stain until stage 11 indicating that zygotic expression of MSL-1 and MLE is low or absent during the initial stages of embryogenesis (see Fig. 4 and below for discussion). MSL-2 starts to be expressed following fertilization (Fig. 2B) , consistent with the lack of an msl-2 maternal effect (Belote and Lucchesi, 1980 ) and lack of msl-2 transcripts in ovaries (Kelley et al., 1995) . The onset of initial MSL-2 expression is difficult to assess using this method, as any staged collection may consist of a small number of older embryos held in the mother.
To determine when sub-nuclear localization of the MSL proteins could be detected, we examined staged embryos by confocal microscopy. Fig. 3 shows representative stages of male embryos stained with HRP-conjugated antibodies to establish the temporal profile of each MSL. Underneath each HRP panel, a confocal image of a similar stage, double-labeled embryo is shown to assess sub-nuclear localization.
In confocal images, MSL-1 is detected in red and MSL-2, MLE and H4Acl6 are detected in green. Comparison of the embryos in the first column shows that the first antigen detectable with subnuclear localization was MSL-1 in stage 5 male embryos. At the same stage MSL-2 was also male specific, but detected as weak, diffuse staining. MLE, present in high amounts in males and females, appeared unlocalized. H4Ac16 was not detectable at stage 5. Comparison of embryos in the second column shows that MSL-2 begins to exhibit sub-nuclear localization in some nuclei at stage 7 while MLE and H4Ac16 are first detected as subnuclear in stage 8 embryos. Finally, the third column shows that by the end of stage 8, all components, including histone H4Ac16, were co-localized in male nuclei, presumably to the X chromosome. Although these results suggest an order to MSL assembly on the X chromosome, the genetic requirements for X localization of each MSL suggest that the MSLs are interdependent from the earliest stages (see below).
Interdependence of the MSL proteins in embryogenesis
We counterstained embryos with propidium iodide in order to further characterize the sub-nuclear staining observed with anti-MSL antibodies. We found that each MSL protein co-localizes with only part of the DNA in males, but not in females (Fig. 4) 1-5 h after laying. on, overnight collection; >7 embryos aged more than 7 h after laying. no mat., embryos laid by tn~1-I~~~~ (A) or mle' (C) mothers thus lacking the maternal component for these genes. chromatin in interphase nuclei, usually located in the periphery.
In embryos that lack maternal MSL-1, we failed to detect significant MSL-1 staining until stage 1 I (Figs. 2A,  4) . In embryos lacking maternal MLE, MLE levels were markedly reduced until stage 11 (Figs. 2C, 4) . In order to determine the effect of reduced levels of MSL-I or MLE on the sub-nuclear localization of the other MSL proteins, we immunostained progeny of homozygous msl-1 or mle mothers. We found that stage 9 embryos lacking maternal MSL-1 failed to localize either MSL-2 or MLE, and analogous embryos lacking maternal MLE failed to localize both MSL-1 and MSL-2 (Fig. 4) . In each panel the DNA was stained with propidium iodide (red) while each MSL protein was revealed with FITC conjugated antisera (green). In wild type males the protein decorates only part of the overall chromatin in interphase nuclei and in nuclei at various stage of mitosis (these panels represent a collection of nuclei from different parts of the embryo). The arrow points to a possible metaphase nucleus where only one chromosome is stained with anti-MSL-2. In wild type females, there is no MSL-1 or MSL-2 detection while MLE is nuclear but is not associated with DNA. Stage 9 heterozygous male embryos from homozygous msl-I-mothers, thus lacking maternal MSL-I (no mat. msl-I), do not stain with anti-MSL-1 which indicates that zygotic expression does not start until later in embryogenesis.
In these embryos the MSL-2 and MLE proteins fail to associate with the DNA. In stage 9 heterozygous embryos lacking maternal mle (no mat mle), where the MLE expression is reduced, the MSL-1 staining is nuclear but diffuse and MSL-2 fails to associate with DNA.
msl-2/msl-2 Fig. 5 . MSL-2 is necessary for the sub-nuclear localization of MSL-1 and MLE. Male embryos lacking msi-2 (msl-2/m&2) do not show the subnuclear localization of MSL-1 or MLE which is evident as dots in their heterozygous brothers (md-2/+). Heterozygous embryos can be recognized because of the dark stripes due to reactivity to antibodies against p-galactosidase expressed from the CyOwglacZ, m&2+ second chromosome. X chromosome from the earliest detection of sub-nuclear staining.
Male embryos lacking zygotic MSL-2 failed to localize MLE (Fig. 5) , consistent with the interdependence of the MSLs seen later in development (Gorman et al., 1993; Palmer et al., 1994; Gorman et al., 1995 ; L. Lyman and M.I. Kuroda, unpublished) . MSL-1 levels in msl-2 mutant males were reduced to the wild type female level, consistent with previous observations that MSL-1 levels are dependent on the presence of functional MSL-2 Gorman et al., 1995; Kelley et al., 1995) . Negative regulation by Sex Zethal (Sxl), which is expressed by the end of stage 4 in females (Bopp et al., 1991) coupled with stabilization of a labile MSL-1 protein by MSL-2 (expressed only in males) (Kelley et al., 1995) could explain why initially we observe MSL-1 in both sexes, while after stage 5 the protein is detectable only in males (see male and female embryos in Fig. 1 ).
We observed a strong localized anti-histone H4Ac16 signal in males only after detection of the MSL proteins in a sub-nuclear pattern at the beginning of stage 9 (Figs.  3, 6A,C) . The H4Ac16 signal in females was weak and diffuse (Fig. 6B,D) . In stage 9 heterozygous embryos from homozygous msl-I-mothers, thus lacking maternal MSL-1, we did not detect H4Ac16 (Fig. 6E ). Even at stage 11, embryos with the same genotype showed a markedly reduced H4Ac16 staining compared with wild type (Fig. 6F) . The delay in the appearance of H4Ac16 in embryos lacking maternal MLE or MSL-1 provides additional evidence that the establishment of a putative MSL dosage compensation complex is necessary for the Xchromosome detection of histone H4 acetylated at lysine 16 (Bone et al., 1994) .
Germ cells
Male germ cells stain with anti-MLE, but not with anti-MSL-1 or anti-MSL-2 ( Fig. 7 and data not shown). Pole cell nuclei of stage 4 embryos reacted positively with anti-MLE antibodies (Fig. 7A) but not with anti-MSL-1 (Fig. 7B ) which at this stage is detected in the rest of the embryo. Fig. 7D shows a male embryo at stage 12 stained with anti-MLE (red) and anti-vasa antibodies, which labels the cytoplasm of germ cells (green) (Hay et al., 1988; Lasko and Ashburner, 1988) . The appearance of MLE staining inside these cells is diffuse (Fig. 7E) , in contrast to the sub-nuclear, localized pattern in the surrounding somatic cells. To test whether only MLE is present in germ cells, we labeled embryos with anti-MLE, anti-MSL-1 and anti-vasa. In Fig. 7C the MSL-I and vasa protein are both revealed in green (because our confocal microscope has only two channels) but the clear difference in the localization (nuclear for MSL-1 and cytoplasmic for vasa) would permit one to distinguish the two antigens. Germ cell nuclei did not stain for MSL-1 (absence of green), while MLE was present (red). A striking difference is observed in the somatic cells, where MLE is localized to the X. This is not surprising if MLE cannot associate to the X without the other MSLs as observed in third instar polytene chromosomes (Gorman et al., 1993) . The presence of MLE protein in the germ cells, is consistent with genetic evidence that mle function is necessary in male germ cells while msl-1 and msl-2 are not (Bachiller and Sanchez, 1986 ).
Discussion

The A4SLs are interdependent during embryogenesis
The MSL proteins co-localize with exquisite specificity to the male X chromosome. To explore the basis for X chromosome recognition, we examined when the MSL proteins are first seen in a sub-nuclear localization, and whether, in the initial stages of binding we could observe an order to their assembly. We could detect co-localization of MSL-1, MSL-2, and MLE in a sub-nuclear pattern since the germ band extension stage of embryogenesis. The sub-nuclear pattern of each MSL was dependent on the others since the initial stages of detection, suggesting that stable X chromosome association requires complex formation. Removal of maternal MLE or MSL-1 delayed detection of the other MSL proteins in a subnuclear pattern until stage 11. Removal of zygotic MSL-2 resulted in failure of MLE to localize in a subnuclear dot, and decreased levels of MSL-1, which was unlocatized.
Although MSL-1 was the first factor we could detect in a sub-nuclear pattern (in wild type stage 5 embryos), it may be the easiest to detect specifically on the X chromosome due to low background nuclear staining. This could be explained if free MSL-I protein in the nucleoplasm is rapidly degraded. Previous studies suggest that MSL-1 is labile in the absence of protein complex formation. Low MSL-1 levels are observed in msl-2-mutant males Gorman et al., 1995) . In addition, ectopic expression of MSL-2 in females causes an increase in MSL-1 levels, correlating with detection of MSL-1 and MSL-2 on the female X chromosomes (Kelley et al. 1995) . The interdependence of the MSLs since embryogenesis supports the hypothesis that stable X chromosome association requires interaction between the individual MSL proteins.
When does m&dependent dosage compensation begin?
In Drosophila, zygotic transcription is established by the cellular blastoderm stage. However, dosage compensation of only two X-linked genes has been examined in embryogenesis (Gergen, 1987; Polito et al., 1990) . The genetic requirements for dosage compensation of one of these, runt, were determined by Gergen (1987) . runt is not controlled by the msl pathway, indicating that an mslindependent mechanism acts during embryogenesis. There are two general models for the relationship between the msl-dependent and -independent dosage compensation pathways. In one model, the two pathways are temporally distinct, with the msl-dependent mechanism acting only later in development (Cline, 1984) . This model is based primarily on the observation that msl mutant males die as late larvae. However, these mutants are severely retarded in their development, so their late lethality could be due to the cumulative effect of insufficient X-linked gene expression since embryogenesis.
An alternative model is that the two pathways act on separate sets of X-linked genes and function in parallel during development.
It is not known how the msl-independent pathway operates, but recent data suggest that Sxl may function to reduce the stability or translation of a subset of X-linked transcripts in females (Kelley et al., 1995) . Based on the dosage compensation properties of partial loss-of-function Sxl mutants, Bernstein and Cline (1994) suggest that the mslindependent mechanism is not limited to embryonic development. In this work we have shown that the MSL proteins are associated with the X chromosome and are interdependent since early embryogenesis, suggesting that msl-dependent dosage compensation is not limited to larval development. Although the appropriate localization of the MSL proteins during embryogenesis does not directly address when they are functional, histone H4Ac16 is also on the male X during embryogenesis and is dependent on the msl functions, supporting the idea that msl-dependent dosage compensation is active at this time in development. Thus, we favor a model in which two pathways of dosage compensation act in parallel on separate sets of Xlinked genes.
MLE activity in the germline
The molecular basis for sex determination in the germline differs significantly from the soma and it not known whether dosage compensation occurs in the germline.
Genetic experiments have shown that msl-1 and msl-2 are not required in the male germline (Bachiller and Sanchez, 1986) indicating that, if dosage compensation is occurring, it must act through a different pathway. Our molecular data reveal the presence of MLE protein in the germ cells, in agreement with the genetic requirements for mle in these cells (Bachiller and Sanchez, 1986) . In embryonic germ cells we did not detect MSL-1 or MSL-2 and we could not detect a specific association of MLE with the X. A lack of X association of MLE would fit with polytene chromosome immunostaining in msl mutants, which revealed that MLE alone could not bind appreciably to the X (Gorman et al., 1993) . A role of MLE in germ cell dosage compensation is difficult to reconcile with the lack of X-chromosome association that we observed in these embryos. However, it is not known when X chromosome number is assessed in the germ line, which would be a prerequisite to dosage compensation. Preliminary experiments reveal that MLE appears nuclear, but not chromosomal in spermatocytes and spermatids, and that MSL-1 is not present in these nuclei (L. Rastelli and M.I. Kuroda, unpublished) .
These results suggest that MLE in the male germ cells may not be involved in dosage compensation but may act in some other aspect of spermatogenesis.
Does the male X chromosome position reveal a defined nuclear domain?
Examination of interphase male nuclei labeled with anti-MSL antisera reveals that the X chromosome, decorated by the MSLs and H4Ac16, always appears located on the periphery of the nuclei. Similar results were described by Lavender et al. (1994) in squashed larval neuroblasts, and suggest that the euchromatic part of the male X, which is decorated by the MSLs, might occupy a specific nuclear domain. A growing body of evidence obtained studying many organisms suggests that the nucleoplasm is organized in domains defined by the concentration of active enzymes, e.g. the DNA replication, RNA transcription and RNA splicing machinery (see Rosbash and Singer, 1993) or by specific chromosomal structures, e.g. association of the centromeres and telomeres with the nuclear envelope in yeast and Drosophila (reviewed in Gilson et al., 1993) . Ultrastructural analysis of the nucleus reveals the presence of several different electron dense regions or nuclear bodies (NB). In the context of this work, one member of the RING finger family, human PML, is specifically associated with a particular NB (Koken et al., 1994) . In addition the Drosophila Polycomb group (PC-G) proteins show a speckled appearance in interphase nuclei (Messmer et al., 1992) . Several authors have postulated models in which particular regulatory phenomena, e.g. telomere silencing, position effect variegation, and PC-G repression, are sequestered in specific nuclear domains and that PC-G and Suppressor or Enhancer of variegation proteins may participate in the formation and maintenance of these structures (Paro, 1993; Karpen, 1994) . In the case of dosage compensation, one can speculate that the positioning of the male X might be necessary to limit hypertranscription only to this chromosome and might be associated with the sequestering of certain activities, for example the acetyltransferase necessary to produce H4Ac16, to a region of the nuclear envelope.
Experimental procedures
Fly stocks and mutants
Flies were maintained at 25°C on standard cornmealmolasses-yeast-agar medium and the embryos were collected on molasses-agar plates. The wild type strain used in this work is wJ118. The mlel, and msl-2' mutants are described in Lindsley and Zimm (1992) . The In(Z)msl2p22 mutant is described by Kelley et al. (1995) , msl-1y269 and msl-ZY216 are described by Palmer et al. (1993) .
To distinguish among male and female embryos we used the FM7 chromosome carrying 1acZ under the control of the ftz regulatory region (FM7ftzlacZ). Embryos from wild type females crossed to FM7JszlacZ males were collected and double stained with anti-MSL antibodies detected with horse radish peroxidase (HRP), see below, and anti-p-galactosidase antibodies (detected with alkaline phosphatase). Only the female embryos receive the FM7 chromosome and thus react with the anti&gal antibodies. In a similar way we used the FM7ftzlacZ to analyze the MSL maternal component. We crossed FM7ftzlacZ males, otherwise wild type, to females homozygous for mle' or to females homozygous for several alleles of msl-2. All the progeny from these crosses lack the respective maternal component and half of the zygotic dose.
To distinguish between wild type and msl mutant embryos, second chromosomes carrying msl mutations were balanced with a CyO chromosome carrying LacZ under the control of the wg regulatory region (CyOwglacZ). We also stained the progeny of FS47ftzlacZ; msl mutant/CyOwglacZ males to homozygous msl mutant females. After double immunostaining with anti-j?-galactosidase and anti-MSL, we could distinguish the following four classes of embryos: Mutant males, heterozygous males, mutant females and heterozygous females. In these experiments we could compare wild type and mutant males with the certainty that they were indeed mutant males and not females.
After a series of experiments which permitted us to observe the difference in antibody staining between females and males and between wild type and mutants, the same experiments were repeated without staining for /I-galactosidase expression for photographic presentation, as the HRP staining is clearest in the absence of the alkaline phosphatase reaction.
Western blots
We collected embryos laid by (1) virgin females (unfertilized embryos), (2) wild type females crossed to F347ftzlacZ males and 3) females homozygous for mle' or msl-lY269, thus lacking the MLE or MSL-1 maternal com-ponent, crossed to FM;rfrzlacZ males. Embryos were either collected for l-5 h when zygotic expression is low or not detectable, or for 7-24 h, when zygotic expression is readily detectable. Crude protein extracts were prepared and transferred to nitrocellulose for blotting as in Palmer et al. (1994) . The affinity-purified antibodies used to detect the MSL proteins in Western blots and/or in embryo whole mounts were: MSL-1BB (Palmer et al., 1993) ; MSL-1FL ; MSL-2 ~50 (Kelley et al., 199.5 ): MLE12 and MLE25 ; and H4Acl6/Rl4 (Turner and Fellows, 1989) .
4.3.
Immunohistochemical staining of embryos Embryos were fixed, stained and mounted using the method of Lawrence and Johnston (1989) which uses the Vectastain ABC kit (Vector). When necessary for double labeling, the /?-galactosidase was detected using mouse anti-/I-galactosidase antibody (Promega) diluted l/1000, followed by alkaline phosphatase conjugated anti-mouse antibody (Promega). After developing the HRP reaction to detect the anti-MSL staining, the embryos were washed twice for 3 min in alkaline phosphatase buffer (100 mM Tris, pH. 9.5, 100 mM NaCl, 5 mM MgCl* and 0.1% Triton X-100) and then the alkaline phosphatase reaction was developed using lO,&ml of NBT and 5,uYml of BCIP from the Promega Kit.
Immunojluorescence
We used the Molecular Dynamics MultiProbe 2001 CLSM confocal microscope to analyze protein distribution within nuclei. To increase the level of signal of the fluorescent detection, we substituted the Vectastain A+B reagents with fluorescein-conjugated streptavidin (Jackson Laboratories) at a dilution of l/200 for 1 h at room temperature (RT) followed by 1 h of rinsing with four changes of buffer at RT. Using the confocal microscope the DNA was visualized by staining the embryos with propidium iodide, which requires a pre-treatment with 2Opg/pl RNase A in PBT for 10 min at the beginning of the last series of rinses. Following a brief rinse in PBT, propidium iodide was added at 1 pgfpl for 5 min and the embryos were rinsed twice for 10 min in PBT.
